[Agents to improve cerebrovascular circulation and cerebral metabolism--vinpocetine].
Tamaki
N
N
Matsumoto
S
S
D000818:Animals; D001921:Brain / Q000378:metabolism; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D006152:Cyclic GMP / Q000378:metabolism; D004285:Dogs; D005947:Glucose / Q000378:metabolism; D006801:Humans; D051379:Mice; D010101:Oxygen Consumption / Q000187:drug effects; D051381:Rats; D014665:Vasodilator Agents / Q000494:pharmacology* / Q000627:therapeutic use; D014748:Vinca Alkaloids / Q000494:pharmacology* / Q000627:therapeutic use
D014665:Vasodilator Agents; D014748:Vinca Alkaloids; C013983:vinpocetine; D006152:Cyclic GMP; D005947:Glucose